Results 91 to 100 of about 30,706 (198)
With cancer causing over 10 million deaths annually, identifying novel therapeutic targets is crucial. SIRT7 is a NAD-dependent deacetylase that regulates oncogenic pathways, making it a promising therapeutic target.
K.M. Tanjida Islam +2 more
doaj +1 more source
Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies [PDF]
With the advent of targeted agents for the treatment of renal cell carcinoma (RCC), overall survival has improved, and patients are being treated continuously for increasingly long periods of time.
Eisen, Tim +7 more
core
Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims. [PDF]
Vyas A +6 more
europepmc +1 more source
Key aspects of medication adherence to oral anticancer drugs: A literature review
At least 25% of the anticancer drugs are intended for oral use, while the creation and rapid introduction of oral drugs into clinical practice is constantly growing. Between 2006 and 2021, 80 oral forms of anticancer drugs were approved. It has been shown that patients prefer oral therapy to intravenous therapy if such a replacement is possible with ...
Ju. A. Agafonova +2 more
openaire +1 more source
Oral considerations in pediatric patients with acute lymphoblastic leukemia [PDF]
Introduction: Acute lymphocytic leukemia is one of the most common type of cancer in children and it is characterized by excessive and disordered immature leukocytes in the bone marrow.
Aroso, Ricardo
core
Inhibition of Giardia duodenalis by isocryptolepine -triazole adducts and derivatives
Giardia duodenalis, a widespread parasitic flagellate protozoan causing giardiasis, affects millions annually, particularly impacting children and travellers.
Supaluk Popruk +9 more
doaj +1 more source
Celecoxib in breast cancer prevention and therapy. [PDF]
Breast cancer has a high incidence worldwide. The results of substantial studis reveal that inflammation plays an important role in the initiation, development, and aggressiveness of many malignancies. The use of celecoxib, a novel NSAID, is repetitively
Cao, Wei +4 more
core
The use of mushroom preparations in malignancies [PDF]
Medicinal mushrooms have been recommended for centuries in Asia. Specific types of mushrooms are presented, as well as evidence for their immunopotentiating effects and their use as adjuvant therapy for specific types of ...
Staff, Clinic
core +1 more source
Palbociclib, an oral inhibitor of cyclin-dependent kinase 4 and 6, is approved for the treatment of metastatic breast cancer. This study investigated the influence of diverse clinical and biological factors—age, renal function, genetic variations, and ...
Elena Peruzzi +14 more
doaj +1 more source
Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents
Yun Jiang,1 Karen E Wickersham,2 Xingyu Zhang,1 Debra L Barton,1 Karen B Farris,3 John C Krauss,4 Marcelline R Harris1 1University of Michigan School of Nursing, Ann Arbor, MI, USA; 2University of South Carolina College of Nursing, Columbia, SC, USA ...
Jiang Y +6 more
doaj

